Biotech · Private company · Atlanta, GA, US

Trevena Inc

SEC CIK 0001429560

Track this companyFree. Adds Trevena Inc to your Dealase workspace and tells you when its record changes.

Clinical trials60 recruiting or active

Pipeline programs5From trials and the company's site

Disclosed deals0None found yet

Cash runwayNot availablePrivate: no SEC financials

Pipeline5

Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After AbdominoplastyPHASE3 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02820324 · fetched Nov 12, 2026
Study of Oliceridine (TRV130) for the Treatment of Moderate to Severe Acute Pain After BunionectomyPHASE3 · COMPLETED · started May 1, 2016ClinicalTrials.gov NCT02815709 · fetched Nov 12, 2026
A Open-label Study to Evaluate the Safety of TRV130 in Patients With Acute PainPHASE3 · COMPLETED · started Dec 1, 2015ClinicalTrials.gov NCT02656875 · fetched Nov 12, 2026
A Pilot Study of TRV130 for the Treatment of Fracture PainPHASE2 · TERMINATED · started Oct 20, 2015ClinicalTrials.gov NCT02520297 · fetched Nov 12, 2026
A Study of TRV130 for the Treatment of Pain After AbdominoplastyPHASE2 · COMPLETED · started Dec 1, 2014ClinicalTrials.gov NCT02335294 · fetched Nov 12, 2026
A Study of TRV130 for the Treatment of Pain After BunionectomyPHASE2 · COMPLETED · started Apr 1, 2014ClinicalTrials.gov NCT02100748 · fetched Nov 12, 2026